Inhalation Anesthesia Market to Observe Strong Development By 2025

Global inhalation anesthesia market is poised to gain massive momentum over the forecast period of 2019 to 2025. This can be credited to the significant rise in product adoption primarily driven by increasing surgical procedures related to respiratory, neurological and chronic disorders. Additionally, supportive reimbursement scenario across developed countries and availability of several insurance schemes for quick and affordable surgical procedures will increase the application of inhalational anesthetics, thereby supporting the industry growth.

Speaking about the rising need for of ambulatory surgeries, the dramatically increase has resulted from the consistent improvements in anesthesia techniques with reduced side effects. Furthermore, suitable discharge criteria and minimal invasive surgical techniques have also influenced the rate of occurrence of ambulatory surgeries. In the present scenario, ambulatory surgical centers (ASCs) are becoming the prominent choice for patients as well as physicians because of their ability to perform complex surgeries in a very short period of time, inherently propelling inhalation anesthesia industry size.

Get sample copy of this research report @

The product terrain of inhalation anesthesia market includes Sevoflurane, Desflurane, Xenon, and Isoflurane which are widely used during clinical surgeries. Among these, Sevoflurane is known as general anesthetic and is broadly adopted as an agent for inhalational inductions. Sevoflurane is extensively useful in children and adults for both induction and maintenance purpose, since it exhibits low reactivity with other drugs and minimal cardiovascular and respiratory side effects.

Over the past few years, the health services sector has expanded at a significant rate on account of an increase in demand for modern healthcare facilities, high-grade medical infrastructure and improved health consciousness among people. This has helped key players to direct their efforts towards expanding their geographical reach, grow their physician networks and build R&D capabilities, which will fuel inhalation anesthesia market size. Joint ventures, partnerships and collaborative arrangements are taking place within the healthcare sector, providing ample opportunities to various pharma companies to establish their presence in the market.

Asia Pacific inhalation anesthesia market had registered a substantial revenue share of 20% in 2018 and is estimated to observe a significant growth rate over the forecast period. The growth can be attributed to enhanced patient care along with rising deployment of advanced technologies for effective patient monitoring across the regional healthcare facilities. Moreover, rising healthcare expenditure and elevating demand for surgical procedures will further enhance the business growth in Asia Pacific.

Prominent market players operating in inhalation anesthesia market such as Halocarbon Products, Baxter International, Abbvie, Piramal, Hikma Pharmaceuticals, Lunan Pharmaceutical, Jiangsu Hengrui Medicine and Fresenius Kabi are focused on new product launches, geographical expansion, mergers and acquisitions to gain a strong foothold in the market.

Request for a Customization of this research report @

Partial Chapter of the Table of Content

Chapter 4. Inhalation Anesthesia Market, By Product

4.1. Key segment trends

4.2. Sevoflurane

4.2.1. Market size, by region, 2014 – 2025 (USD Million)

4.2.2. Market size, by region, 2014 – 2025 (000’ Units)

4.3. Desflurane

4.3.1. Market size, by region, 2014-2025 (USD Million)

4.3.2. Market size, by region, 2014 – 2025 (000’ Units)

4.4. Isoflurane

4.4.1. Market size, by region, 2014 – 2025 (USD Million)

4.4.2. Market size, by region, 2014 – 2025 (000’ Units)

4.5. Others

4.5.1. Market size, by region, 2014-2025 (USD Million)

4.5.2. Market size, by region, 2014 – 2025 (000’ Units)

Chapter 5. Inhalation Anesthesia Market, By Application

5.1. Key segment trends

5.2. Induction

5.2.1. Market size, by region, 2014-2025 (USD Million)

5.3. Maintenance

5.3.1. Market size, by region, 2014-2025 (USD Million)

Chapter 6. Inhalation anesthesia Market, By End-use

6.1. Key segment trends

6.2. Hospitals

6.2.1. Market size, by region, 2014-2025 (USD Million)

6.3. Ambulatory surgical centers

6.3.1. Market size, by region, 2014-2025 (USD Million)

Browse complete Table of Contents (ToC) of this research report @